RETTA BRIGHT: Open Payments
NPI 1174928667 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 10 payments from 6 companies in 2025. Trend: 2023 $521 · 2024 $155 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $169 |
| ABBVIE INC. | 2 | $40 |
| Boston Scientific Corporation | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: FANAPT, VRAYLAR, LithoCatch, REXULTI, CAPLYTA, Auvelity.
Industry payments across GA — which companies pay providers there.
